
Gene therapy to treat choroideremia is one step closer to reality thanks to a new study.

Gene therapy to treat choroideremia is one step closer to reality thanks to a new study.

Topical glaucoma drops have potential for causing profound structural soft-tissue changes.

Dr. McDonald advises taking a second visit to an established dry eye center of excellence a few months after your first visit. Begin by implementing the osmolarity units, train staff, and promote that your office is now a center of dry eye excellence. Watch more on how to be successful!”

While many people across the United States are hosting barbeques, attending parades and firework displays, and picnicking with their families today, ophthalmologists may find themselves celebrating Independence Day a little differently-handling emergencies due to firework-related eye injuries.

In our continued series, Uday Devgan, MD, FACS, shares what he wishes he knew in med school.

The first case series report of femtosecond laser flap creation for LASIK in eyes that have undergone radial keratotomy showed the technique was successful when novel settings were used. No significant intraoperative or postoperative complications were reported in the 27 eyes in the study, and uncorrected visual acuity improved significantly.

Patients with symptomatic vitreomacular adhesion (VMA) find that a single intravitreal injection of ocriplasmin improves their vision, according to an ancillary analysis of two multicentre randomised clinical trials reported in JAMA Opthalmology.

Google Glass may be the answer for retina surgeons who struggle to record scleral buckling surgery, according to a recent study published in JAMA Ophthalmology.

In the first of a four-part series, Arun C. Gulani, MD, discusses the concept and approach to designing primary cataract surgery.

One thing that is interesting about the Medicare data is how much goes to the top 1% of physician billers.

Managers can teach staff many skills but often the most difficult lesson for employees to learn is they need to be aware of the chaos they consciously or unconsciously create.

Real-world experience with ocriplasmin indicates it is an effective, safe, and cost-effective treatment for symptomatic vitreomacular adhesion in properly selected eyes.

The Raindrop Near Vision Inlay (Revision Optics) improves near-visual performance without added visual disturbance in pseudophakic patients.

Ophthalmologists should suspect autoimmune retinopathy if a patient presents with an unexplained visual loss.

In what is believed to be the largest reported series of spontaneous in-the-bag IOL dislocation, investigators analyze presenting characteristics and outcomes for 21 eyes with a capsular tension ring (CTR) and 84 eyes without one.

Small incision lenticule extraction (SMILE), which has not yet been approved for refractive correction in the United States, may be less accurate and produce more irregular astigmatism than LASIK or PRK because of the imprecision resulting from the two incisions needed to create the lenticule. In addition, the technique for potential enhancements needs improvement. However, the treatment is promising and may stand the test of time as the technology advances.

Take-home message: The various excimer ablation technologies have their pros and cons. Wavefront-guided ablations using aberrometry can provide the vast majority of patients with uncorrected vision of 20/20 with fewer postoperative visual symptoms.

Techniques for performing corneal collagen crosslink (CXL) are being evaluated and adapted, and at the same time, new applications are being developed.

Femtosecond lasers differ in their indications, energy delivery parameters, and hardware features. Understanding the implications of these factors will enable an objective assessment of the available technology.

Physicians should focus on referral criteria in screening technology rather than the instrument itself.

In this article, the authors present their recent findings on drug-eluting, extended-wear contact lenses for glaucoma and discuss how these lenses may provide week-long IOP reduction with just one day of wear.

Dr Thomassen shares his personal experiences with the MFR2 IOL, including reasons why the MFR2 is his lens of preference, clinical findings from a real-life setting and considerations for future use.

In this article, Dr Ianchulev discusses MIGS supraciliary microstenting, a compelling new approach for outflow enhancement that results in sustained reduction of IOP and anti-hypertensive topical medication use in OAG patients.

Exfoliative glaucoma can prove to be a particularly difficult disease for opthalmologists to manage. In this article, aspects of IOP-lowering therapy specific to this type of glaucoma are considered, as well as the range of treatments available and the potential advantages and challenges associated with each therapy.

In this article, the authors discuss the benefits of nutritional supplementation in preventing AMD progression and consider which AREDS formulation is the most appropriate in smokers and non-smokers.

Despite an increase in Medicare beneficiaries since 1994, the number of glaucoma-related surgeries has decreased, according to a recent study published in Ophthalmology.

Careful preparation that includes planning ahead and going into surgery armed with the proper equipment and alternative strategies will facilitate easy and atraumatic explantation when performing IOL exchange, said Stephen S. Lane, MD.

Gifted surgeon, innovator, teacher, humanitarian, and life changer. These are the words used to described Robert Sinskey, MD, by some of his closest ophthalmic colleagues.

A novel eyewear prototype wants to be the solution for those seeking wearable technology to track fitness and activities, but hate the bulky equipment that is required to be worn on wrists or clothing.

Intravitreal aflibercept 2 mg every 8 weeks after 5 initial monthly doses (IVT-AFL 2q8) improved visual acuity outcomes in eyes with center-involved diabetic macular edema (DME) to a greater extent than intravitreal ranibizumab 0.5 mg as needed (IVR 0.5 mg PRN), though vascular endothelial growth factor (VEGF) inhibition with either IVT-AFL or IVR is efficacious and appears safe